Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC β-lactamase: Implications for antibiotic use

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 995-1000

  Choi, Sang Ho ^a,b   Jung, Eun Lee ^a,b   Su, Jin Park ^a,b   Choi, Seong Ho ^a,b   Lee, Sang Oh ^a,b   Jeong, Jin Yong ^a,b   Kim, Mi Na ^a   Jun, Hee Woo ^a,b   Yang, Soo Kim ^a,b,c  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE AMPC; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BILE DUCT; BILIARY TRACT INFECTION; CATHETER INFECTION; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORGANELLA MORGANII; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; SERRATIA MARCESCENS; SKIN INFECTION; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 40549134482     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01083-07     Document Type: Article

References (13)

1. Bouza, E., and E. Cercenado. 2002. Klebsiella and Enterobacter: antibiotic resistance and treatment implications. Semin. Respir. Infect. 17:215-230.
2. Chow, J. W., M. J. Fine, D. M. Shlaes, J. P. Quinn, D. C. Hooper, M. P. Johnson, R. Ramphal, M. M. Wagener, D. K. Miyashiro, and V. L. Yu. 1991. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115:585-590.
3. Diekema, D. J., M. A. Pfaller, R. N. Jones, G. V. Doern, K. C. Kugler, M. L. Beach, H. S. Sader, et al. 2000. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. Int. J. Antimicrob. Agents 13:257-271.
4. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections. Am. J. Infect. Control 16:128-140.
5. Ho, P. L., R. H. Shek, K. H. Chow, R. S. Duan, G. C. Mak, E. L. Lai, W. C. Yam, K. W. Tsang, and W. M. Lai. 2005. Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. J. Antimicrob. Chemother. 55:326-332.
6. Jacobson, K. L., S. H. Cohen, J. F. Inciardi, J. H. King, W. E. Lippert, T. Iglesias, and C. J. VanCouwenberghe. 1995. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms. Clin. Infect. Dis. 21:1107-1113.
7. Jacoby, G. A., and P. Han. 1996. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 34:908-911.
8. Lee, S. O., Y. S. Kim, B. N. Kim, M. N. Kim, J. H. Woo, and J. Ryu. 2002. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with Enterobacter bacteremia. Eur. J. Clin. Microbiol. Infect. Dis. 21:577-581.
9. Nauciel, C., A. Philippon, E. Ronco, J. Pilliot, M. Guenounou, G. Paul, D. Brunel, and H. D. Outin. 1985. Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins. Presse Med. 14:673-676.
10. Olson, B., R. A. Weinstein, C. Nathan, and S. A. Kabins. 1983. Broad-spectrum beta-lactam resistance in Enterobacter, emergence during treatment and mechanisms of resistance. J. Antimicrob. Chemother. 11:299-310.
11. Pai, H., J. Y. Hong, J. H. Byeon, Y. K. Kim, and H. J. Lee. 2004. High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns. Antimicrob. Agents Chemother. 48:3159-3161.
12. Sanders, W. E., Jr., and C. C. Sanders. 1997. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin. Microbiol. Rev. 10:220-241.
13. Tenover, F. C., R. D. Arbeit, R. Y. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.